Xiangyi Meng, PhD

This retrospective analysis aimed to identify the percentage of individuals with Alzheimer's disease who have a sustained response with rivastigmine patch, rivastigmine capsules, or placebo.

This study evaluates the long-term safety, tolerability, and efficacy of switching from donepezil to rivastigmine transdermal patches in patients with mild to moderate Alzheimer's disease.